Jiangsu Hualan New Pharmaceutical Material (301093) Revenue Breakdown - Main Composition

63.80
-0.50-0.78%

Market Closed Jan 16 15:00 CST

10.48BMarket Cap207.14P/E (TTM)

Jiangsu Hualan New Pharmaceutical Material (301093) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

覆膜胶塞151.5M49.07%

常规胶塞149.76M48.50%

Other7.5M2.43%

By Industry

Currency:CNY

2025/H1

Stock NameRevenueRatio

Pharmaceutical manufacturing industry305.9M99.07%

Other business2.74M0.89%

Total special adjustments121.99K0.04%

By Country/Region

Currency:CNY

2025/H1

Stock NameRevenueRatio

East China region99.73M32.30%

Total special adjustments95.16M30.82%

Overseas59.47M19.26%

Northeast area51.66M16.73%

Other business2.74M0.89%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More

牛牛課堂

Oct 13, 2025 18:05

[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?

Food流油

Apr 14, 2025 15:43

"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"